Government grant to provide more accurate breast cancer diagnosis

October 25, 2021

Vinnova grants SEK 20 million to the Swedish AI Precision Pathology (SwAIPP) consortia to develop and implement AI-based precision diagnostics in cancer care. The consortia consist of Stratipath, Karolinska Institutet, the pathology clinics in the Kalmar, Västmanland and Skåne regions, Microsoft, Roche Diagnostics, Philips, Bröstcancerförbundet, Prevas and Helseplan.

MORE NEWS:

Stratipath And Proscia Announce Partnership, Paving The Way To Bring Relapse Risk Prediction To More Breast Cancer Patients

Stratipath secures its position on the esteemed startup list for the second consecutive year.

Stratipath co-founders, Mattias Rantalainen and Johan Hartman are receiving the prestigious Karolinska Institutet’s award for innovation and utilisation.

”AI can be a game-changer” An exclusive interview featuring Stratipath co-founder Johan Hartman in the Swedish wellness magazine ”Må Bra”

Stratipath And Proscia Announce Partnership, Paving The Way To Bring Relapse Risk Prediction To More Breast Cancer Patients

Professor Jonas Bergh, will be leading our scientific advisory board

The Swedish deep-tech company Stratipath announces its integration with Sectra, one of the most expanding PACS systems for digital pathology

Government grant to provide more accurate breast cancer diagnosis

”AI can be a game-changer” An exclusive interview featuring Stratipath co-founder Johan Hartman in the Swedish wellness magazine ”Må Bra”

Stratipath has been recognized as one of the innovative healthcare startups hailing from Stockholm.

Stratipath co-founder Mattias Rantalainen is featured in this article by Healthcareineurope.com

”The path from academic research to precision diagnostics in routine health care” Stratipath co-founder is writing an article about Stratipath and the research behind in ”Oncology Sweden”. (Swedish only)

Government grant to provide more accurate breast cancer diagnosis

MORE NEWS:

Stratipath And Proscia Announce Partnership, Paving The Way To Bring Relapse Risk Prediction To More Breast Cancer Patients

Stratipath secures its position on the esteemed startup list for the second consecutive year.

Stratipath co-founders, Mattias Rantalainen and Johan Hartman are receiving the prestigious Karolinska Institutet’s award for innovation and utilisation.

”AI can be a game-changer” An exclusive interview featuring Stratipath co-founder Johan Hartman in the Swedish wellness magazine ”Må Bra”

Press releases:

Stratipath And Proscia Announce Partnership, Paving The Way To Bring Relapse Risk Prediction To More Breast Cancer Patients

Professor Jonas Bergh, will be leading our scientific advisory board

The Swedish deep-tech company Stratipath announces its integration with Sectra, one of the most expanding PACS systems for digital pathology

Government grant to provide more accurate breast cancer diagnosis

IN THE MEDIA:

”AI can be a game-changer” An exclusive interview featuring Stratipath co-founder Johan Hartman in the Swedish wellness magazine ”Må Bra”

Stratipath has been recognized as one of the innovative healthcare startups hailing from Stockholm.

Stratipath co-founder Mattias Rantalainen is featured in this article by Healthcareineurope.com

”The path from academic research to precision diagnostics in routine health care” Stratipath co-founder is writing an article about Stratipath and the research behind in ”Oncology Sweden”. (Swedish only)